Company Profile

Mesoblast Ltd. (NASDAQ: MESO)
8:00 PM UTC, 07/15/26
Last: $18.24 Change: +1.50 %Change: +8.96% Volume: 488,616
Detailed Quote
Open: $ 17.54   Volume: 488,616
High: $ 18.33   Yield(%) 0.00
Low: $ 17.53   P/E Ratio (ttm): n/a
Dividend ($): n/a   Market Cap ($): 2.17B
EPS ($) -1.06   Shares Out: 129.51M
M = Million B = Billion
Price Performance
% Price Change (last 4 weeks): 30.57
% Price Change (last 13 weeks): 15.81
% Price Change (last 26 weeks): 3.40
% Price Change (last 52 weeks): 60.70
% Price Change (year to date): 1.11
Management Effectiveness
Return on Equity (%): -18.92
Return on Assets (%): -14.03
Return on Invested Capital (%): -14.89
Profitability
Gross Profit Margin (%): 32.96
Net Profit Margin (%): -593.92
Operating Profit Margin (%): -363.58
Price & Volume
50-day Moving Average: $14.75
200-day Moving Average: $16.20
Avg. Daily Vol. (last 50 days): 199,222
Avg. Daily Vol. (last 200 days): 225,071
52-wk high: $21.50
52-wk low: $11.05
Bid: $19.06
Ask: $19.20
Company Information
Mesoblast Ltd. is a biopharmaceutical company, which engages in the research, development, and market of mesenchymal lineage adult stem cell technology platform. Its medicines target cardiovascular diseases, spine orthopedic disorders, oncology and hematology, immune-mediated, and inflammatory diseases. The company was founded by Silviu Itescu on June 8, 2004 and is headquartered in Melbourne, Australia.
Mesoblast Ltd.
55 Collins Street Level 38
Melbourne VI 3000

Phone: 61.3.9639.6036
Fax: 61.3.9639.6030
http://www.mesoblast.com
Per Share Data
Earnings (1year) ($): -0.74
Annual Dividend ($): 0.00
Current P/E Ratio (ttm): n/a
Book Value ($): 4.67
Cash Flow ($): -0.75
Valuation Ratios
Price/Earnings (x): n/a
Price/Sales (x): 76.61
Price/Book (x): 2.33
Price/Cash Flow (x): n/a
Financial Strength
Quick Ratio (x): 1.77
Current Ratio (x): 1.99
LT Debt/Equity (x): 11.94
Total Debt/Equity (x): 21.45



Quotes displayed with 15 minutes delay. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement. News provided by MT Newswires, a Division of MidnightTrader, Inc. Events Data provided by Wall Street Horizon. ©2021 Wall Street Horizon, Inc.